Aman Wang
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
-
- Cancer-related Molecular Pathways
- Peptidase Inhibition and Analysis
Papers in
-
- Ubiquitin and proteasome pathways 8
- Histone Deacetylase Inhibitors Research 3
- RNA modifications and cancer 3
- Glycosylation and Glycoproteins Research 2
- Oncology 8
- Cancer-related Molecular Pathways 2
- Co-authors
- Jiwei Liu (13 shared papers)Zhen Ning (10 shared papers)Qiu Yan (6 shared papers)Jinxiao Liang (3 shared papers)Yunpeng Xie (3 shared papers)Chang Lu (4 shared papers)Qihang Yuan (1 shared paper)Guang Tan (3 shared papers)
- Journals
- Frontiers in Pharmacology (2 papers)Frontiers in Immunology (2 papers)Oncology Reports (2 papers)Oncogene (1 paper)Oncotarget (1 paper)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Aman Wang
21 papers receiving 471 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 104
- Oncology 138
- Molecular Biology 320
- Cell Biology 39
- Immunology 45
Countries citing papers authored by Aman Wang
This map shows the geographic impact of Aman Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aman Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aman Wang more than expected).
Fields of papers citing papers by Aman Wang
This network shows the impact of papers produced by Aman Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aman Wang. The network helps show where Aman Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Aman Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 57 | |
| 2 | 2017 | 49 | |
| 3 | 2014 | 46 | |
| 4 | 2014 | 43 | |
| 5 | 2021 | 38 | |
| 6 | 2014 | 37 | |
| 7 | 2020 | 35 | |
| 8 | Abnormal expression of Nek2 in pancreatic ductal adenocarcinoma: a novel marker for prognosis. | 2014 | 31 |
| 9 | 2017 | 28 | |
| 10 | 2021 | 20 | |
| 11 | 2021 | 15 | |
| 12 | 2019 | 14 | |
| 13 | 2021 | 13 | |
| 14 | 2022 | 9 | |
| 15 | 2024 | 9 | |
| 16 | 2022 | 7 | |
| 17 | 2023 | 6 | |
| 18 | 2025 | 5 | |
| 19 | 2022 | 5 | |
| 20 | 2021 | 5 |
About Aman Wang
Aman Wang is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Cell Biology, having authored 21 papers that have together received 473 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (8 papers), Cancer, Hypoxia, and Metabolism (4 papers), Histone Deacetylase Inhibitors Research (3 papers), RNA modifications and cancer (3 papers), Ferroptosis and cancer prognosis (2 papers), Glycosylation and Glycoproteins Research (2 papers), Cancer, Lipids, and Metabolism (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Cancer Research (104 citations), Oncology (138 citations), Molecular Biology (320 citations), Cell Biology (39 citations) and Immunology (45 citations). Aman Wang has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Jiwei Liu, Zhen Ning, Qiu Yan, Jinxiao Liang, Jinxiao Liang, Yunpeng Xie, Chang Lu, Qihang Yuan, Guang Tan and Zhongyu Wang. Their work appears in journals such as Frontiers in Pharmacology, Frontiers in Immunology, Oncology Reports, Oncogene and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.